India's RBI approves Avenir Investment acquisition of 41.23% stake in Sammaan Capital

Company secretariat cannot close the deal without SEBI final approval

Economic Times ·
Save
Change
India's RBI has approved Avenir Investment RSC Ltd's acquisition of a controlling stake in Sammaan Capital Ltd, approving a Rs 8,850 crore preferential equity infusion for an initial 41.23% stake (potentially rising to 63.36%) and waiving the public notice period, with transaction completion conditional on SEBI's final approval.
Why it matters
RBI's approval establishes Avenir as the prospective controller of Sammaan Capital Ltd and its subsidiary for regulatory reporting and change-of-control records. Any preferential allotment or transfer tied to the Rs 8,850 crore infusion cannot be executed or recognised as a completed change of control until SEBI grants its final approval.
Implications
  • Company secretariat and corporate actions teams at Sammaan Capital Ltd must not effect the Rs 8,850 crore preferential equity allotment or any change-of-control transfer until SEBI grants final approval — filings or transfers made before SEBI clearance will not complete the transaction.

Unlock the full brief.

Implications — what this forces you to change
Who is affected — which roles and obligations are exposed
What to watch — binding deadlines and enforcement dates
Real-time alerts — delivered the moment a binding change is published
Clarify with AI — turn any brief into a decision for your role
Start free trial

No credit card · $29/month (~₹2,400) after trial · Active in seconds

Source
View on Economic Times

Clarify answers are AI-generated. Verify against the source before acting.

Clarify with AI — Pro only

You asked:

Clarify turns any brief into answers specific to your role and exposure.

Pro includes

Implications — what this forces you to change
Who is affected — which roles and obligations are exposed
What to watch — binding deadlines and enforcement dates
Real-time alerts — delivered the moment a binding change is published
Clarify with AI — turn any brief into a decision for your role

$29/month (~₹2,400) · Founding rate, locked for life. Cancel anytime.

Start your trial to clarify this brief

You asked:

Clarify is part of Pro. Start a 14-day trial for full access to every brief, unlimited Clarify questions, and real-time alerts.

Pro includes

Implications — what this forces you to change
Who is affected — which roles and obligations are exposed
What to watch — binding deadlines and enforcement dates
Real-time alerts — delivered the moment a binding change is published
Clarify with AI — turn any brief into a decision for your role

$29/month (~₹2,400) after trial. No credit card required. Cancel anytime.